Furthermore, a study on AML reported the selective and potent anti-leukemic effects induced by the aminoalkylindole derivative WIN-55,212-2 (WIN-55), which acts as a parthanatos inductor promoting nuclear translocation of AIF with a glycolytic metabolic drop and hyperactivation of PARP-1. Here, PARP1 is linked to acute myeloid leukemia.